CORE--VIROLOGY FACILITY

$108,748P30FY2000AINIH

Baylor College Of Medicine, Houston TX

Investigators

Linked publications & trials

Paper 39406776 Paper 38975346 Paper 38947062 Paper 38518375 Paper 37880260 Paper 37516317 Paper 37036417 Paper 36844399 Paper 36711878 Paper 36538527 Paper 36399528 Paper 36231015 Paper 36062329 Paper 35794145 Paper 35679138 Paper 35414140 Paper 35143611 Paper 34989321 Paper 34889103 Paper 34799643 Paper 34718349 Paper 34634187 Paper 34373735 Paper 34335611 Paper 34290089 Paper 34242617 Paper 34161280 Paper 34107377 Paper 34092059 Paper 33743191 Paper 33556369 Paper 33547365 Paper 33485667 Paper 33159886 Paper 32792548 Paper 32695845 Paper 32592180 Paper 32541040 Paper 32500803 Paper 32345916 Paper 32320644 Paper 32298026 Paper 32142667 Paper 31964753 Paper 31838858 Paper 31836691 Paper 31765380 Paper 31759187 Paper 31697807 Paper 31696517 Paper 31618426 Paper 31515251 Paper 31451770 Paper 31396406 Paper 31257132 Paper 31198906 Paper 31112138 Paper 31076527 Paper 31068405 Paper 31067451 Paper 30982770 Paper 30948267 Paper 30941128 Paper 30921351 Paper 30878879 Paper 30786885 Paper 30777858 Paper 30761142 Paper 30696983 Paper 30696942 Paper 30646957 Paper 30633903 Paper 30610193 Paper 30501557 Paper 30415998 Paper 30401712 Paper 30388424 Paper 30358421 Paper 30305617 Paper 30267595 Paper 30223431 Paper 30204240 Paper 30165653 Paper 30135482 Paper 30075114 Paper 30070147 Paper 30016639 Paper 30016541 Paper 30013058 Paper 30010888 Paper 29980437 Paper 29939180 Paper 29934134 Paper 29895199 Paper 29848758 Paper 29751067 Paper 29721072 Paper 29679656 Paper 29653981 Paper 29642890

Abstract

The overall objectives of the Virology Core Laboratory are to provide comprehensive virologic tests and services relevant to HIV research, to make available its specialized BSL2/3 laboratory facilities to HW researchers, and to develop new virologic tests that may be useful in clinical and basic research. Major core services include: (1) assays of HW infectivity by means of quantitative micrococultures, (2) assays of HW1 RNA and DNA, (3) characterization of HIV quasispecies, (4) phenotypic characterization of drug resistance and of syncytium-inducing capacity, and (5) processing, storage and shipment of blood specimens and other biological samples from patients with HIV. The core will also provide training and technical advice to researchers interested in developing sophisticated virologic procedures for their HW projects.

View original record on NIH RePORTER →